ClinicalTrials.gov
ClinicalTrials.gov Menu

SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) (SHIVA02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03084757
Recruitment Status : Recruiting
First Posted : March 21, 2017
Last Update Posted : August 22, 2018
Sponsor:
Information provided by (Responsible Party):
Institut Curie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 1, 2020
  Estimated Study Completion Date : April 1, 2020